BridgeBio Pharma (BBIO) Minority Interest (2018 - 2026)
BridgeBio Pharma (BBIO) posted Minority Interest of $10.4 million for Q1 2026, down 1.51% sequentially from $10.6 million in Q4 2025, and up 4.84% YoY from $10.0 million in Q1 2025.
BridgeBio Pharma (BBIO) Minority Interest (2018 - 2026) Analysis & Trends
BridgeBio Pharma has reported Minority Interest for 9 years, with the latest figure at $10.4 million in Q1 2026.
- Quarterly Minority Interest rose 4.84% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 4.84% YoY) and the FY2025 annual result came in at $10.6 million, up 4.42% from the prior year.
- Minority Interest fell to $10.4 million in Q1 2026 per BBIO's latest filing, from $10.6 million in the prior quarter.
- Over five years, Minority Interest peaked at $12.4 million in Q3 2023 and troughed at $336000.0 in Q1 2022.
- A 5-year average of $10.4 million and a median of $10.9 million in 2024 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2022 and 2023: Minority Interest plunged 73.56% in 2022, then soared 3547.62% in 2023.
- Over 5 years, Minority Interest stood at $11.3 million in 2022, then declined by 0.34% to $11.2 million in 2023, then declined by 9.73% to $10.2 million in 2024, then gained by 4.42% to $10.6 million in 2025, then declined by 1.51% to $10.4 million in 2026.
- According to Business Quant data, Minority Interest over the past three periods registered $10.4 million, $10.6 million, and $10.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BridgeBio Pharma | 15.60 Bn | 14.89 Bn | 228.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.34 Mn |
| Mar 31, 2026 | 10.44 Mn |
| Dec 31, 2025 | 10.60 Mn |
| Sep 30, 2025 | 10.32 Mn |
| Jun 30, 2025 | 9.89 Mn |
| Mar 31, 2025 | 9.96 Mn |
| Dec 31, 2024 | 10.15 Mn |
| Sep 30, 2024 | 10.89 Mn |
| Jun 30, 2024 | 11.06 Mn |
| Mar 31, 2024 | 12.15 Mn |
| Dec 31, 2023 | 11.24 Mn |
| Sep 30, 2023 | 12.41 Mn |
| Jun 30, 2023 | 12.05 Mn |
| Mar 31, 2023 | 12.26 Mn |
| Dec 31, 2022 | 11.28 Mn |
| Sep 30, 2022 | 10.43 Mn |
| Jun 30, 2022 | 12.02 Mn |
| Mar 31, 2022 | 336,000.00 |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | 4.56 Mn |